September 29, 2020
FWK Holdings, LLC v. Gilead Sciences, Inc. et al
Case Number:
3:20-cv-06793
See also:
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 11, 2021
Gilead, Bristol-Myers Say Direct Buyers Antitrust Suit Too Late
Gilead Sciences and Bristol-Myers Squibb urged a California federal judge Thursday to nix direct buyers' claims alleging the pharmaceutical companies engaged in anti-competitive conduct to block generic competition and keep HIV medication prices artificially high, arguing the suits should be sent to arbitration or thrown out as time-barred.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login